Avanos Medical
AVNS
467 hedge funds and large institutions have $1.6B invested in Avanos Medical in 2014 Q4 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
18% less call options, than puts
Call options by funds: $7.47M | Put options by funds: $9.08M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$125M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$112M |
| 3 |
GC
Greenlight Capital
New York
|
+$92.5M |
| 4 |
RP
RR Partners
New York
|
+$74.7M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$74.3M |
Top Sellers
AVNS Hedge Fund Activity: Q4 2014 in Review
467 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2014, worth a combined $1.6B.
Buyers outnumbered sellers: 467 funds opened new AVNS positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $125M.
- 467 institutional investors held Avanos Medical (AVNS) as of Q4 2014, up from 0 in Q3 2014.
- Funds reported $1.6B of Avanos Medical stock for Q4 2014.
- 467 funds opened new Avanos Medical positions in Q4 2014 and 0 closed out, a net change of +467 holders.
- The largest Avanos Medical buyer in Q4 2014 was T. Rowe Price Associates, an estimated $125M added.
Based on aggregated 13F filings for Q4 2014.